Validation of indications for enucleation for benign parotid gland tumors

Author:

Taguchi Atsushi12ORCID,Kojima Tsuyoshi12,Okanoue Yusuke1,Kagoshima Hiroki12,Hasebe Koki12,Yamamoto Hirotaka13,Hori Ryusuke14

Affiliation:

1. Department of Otolaryngology Tenri Hospital Nara Japan

2. Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine Kyoto University Kyoto Japan

3. Department of Otolaryngology, Head and Neck Surgery Shizuoka City Shizuoka Hospital Shizuoka Japan

4. Department of Otolaryngology—Head and Neck Surgery, School of Medicine Fujita Health University Toyoake Aichi Japan

Abstract

AbstractBackgroundEnucleation has been reported as a minimally invasive surgery for Warthin's tumor (WT). However, the definite indications for enucleation have not been clarified.MethodsEnucleation was indicated by the following findings: findings of WT, cystic fluid, or benign leukocytes by fine‐needle aspiration cytology; a well‐margined and homogeneous pattern on imaging; and a tumor location in the tail or preauricular area of the parotid gland. We reviewed 552 cases treated with parotid gland surgery in our hospital.ResultsA total of 108 tumors were treated with enucleation and included no malignant solid tumors or pleomorphic adenoma. Enucleation demonstrated low invasiveness and complication rates. Revision surgery for WT reappearance after enucleation was rare and showed minimal scarring, with a lower risk of facial weakness.ConclusionsThe indication criteria for enucleation were validated. Such enucleation is useful, as it is associated with minimal invasiveness, low complication rates, and safety in revision surgery.

Funder

Japanese Foundation for Research and Promotion of Endoscopy

Suzuken Memorial Foundation

Publisher

Wiley

Subject

Otorhinolaryngology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Update on the Treatment of Salivary Gland Carcinomas;Surgical Oncology Clinics of North America;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3